Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)

被引:0
|
作者
Sateria R. Venable
Ayman Al-Hendy
机构
[1] Fibroid Foundation,Department of Obstetrics and Gynecology
[2] University of Chicago,undefined
来源
Advances in Therapy | 2023年 / 40卷
关键词
Uterine fibroids; Heavy menstrual bleeding; Relugolix combination therapy; Patient perspective; Physician perspective;
D O I
暂无
中图分类号
学科分类号
摘要
Uterine fibroids (UF) are common benign tumors in women and are an important health concern in the US and globally. UF can severely compromise a woman's quality of life, thus making it an important health issue. In this podcast, a professor of Obstetrics and Gynecology, University of Chicago (Dr. Ayman Al-Hendy) and the CEO of the Fibroid Foundation (Sateria Venable) provide their perspectives on the diagnosis and management of UF, including common treatments (e.g., myomectomy or hysterectomy). They also discuss Relugolix combination therapy for UF, noting who could benefit from this treatment and how it works. Podcast audio available for this article.
引用
收藏
页码:4127 / 4133
页数:6
相关论文
共 50 条
  • [41] TREATMENT OF SYMPTOMS OF UTERINE FIBROIDS WITH RELUGOLIX COMBINATION THERAPY: EFFICACY AND SAFETY RESULTS FROM THE PHASE 3 LIBERTY 1 CLINICAL TRIAL.
    Al-Hendy, Ayman
    Lukes, Andrea S.
    Poindexter, Alfred, III
    Venturella, Roberta
    Villarroel, Claudio
    Li, Yulan
    McKain, Laura F.
    Stewart, Elizabeth A.
    FERTILITY AND STERILITY, 2019, 112 (03) : E434 - E434
  • [42] Medical management of the violent patient: Clinical assessment and therapy
    Darjee, R
    JOURNAL OF FORENSIC PSYCHIATRY, 2001, 12 (01): : 224 - 232
  • [43] Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
    Emmanuel Ekanem
    Vikram Talaulikar
    Advances in Therapy, 2021, 38 : 137 - 148
  • [44] Medical management of the violent patient: Clinical assessment and therapy
    Vidal, MA
    PSYCHIATRIC SERVICES, 2000, 51 (12) : 1581 - 1581
  • [45] Medical management of the violent patient: Clinical assessment and therapy
    Sadoff, RL
    AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (04): : 689 - 689
  • [46] Medical Therapy for Fibroids: What Next for Ulipristal Acetate?
    Ekanem, Emmanuel
    Talaulikar, Vikram
    ADVANCES IN THERAPY, 2021, 38 (01) : 137 - 148
  • [47] EFFECTS OF RELUGOLIX COMBINATION THERAPY ON BONE MINERAL DENSITY THROUGH 2 YEARS IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS.
    McClung, Michael R.
    Lukes, Andrea S.
    Venturella, Roberta
    Santora, Arthur C.
    Zhai, Dongmei
    Wagman, Rachel B.
    Al-Hendy, Ayman
    FERTILITY AND STERILITY, 2021, 116 (03) : E13 - E13
  • [48] A plain language summary of the safety of relugolix combination therapy and improvement in symptoms in women with uterine fibroids from the LIBERTY 1 and LIBERTY 2 studies
    Al-Hendy, Ayman
    Lukes, Andrea S.
    Poindexter III, Alfred N.
    Venturella, Roberta
    Villarroel, Claudio
    Critchley, Hilary O. D.
    Li, Yulan
    McKain, Laura
    Ferreira, Juan C. Arjona
    Langenberg, Andria G. M.
    Wagman, Rachel B.
    Stewart, Elizabeth A.
    PAIN MANAGEMENT, 2023, 13 (04) : 205 - 211
  • [49] Bone Mineral Density Changes over 52 Weeks in Perimenopausal Women with Uterine Fibroids Treated with Relugolix Combination Therapy vs Untreated Cohort
    Al-Hendy, Ayman
    McLean, Rachel
    Zhai, Dongmei
    McClung, Michael R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2022, 29 (12): : 1475 - 1475
  • [50] Racial Disparities in Medical Management of Uterine Fibroids Prior to Myomectomy or Hysterectomy
    Martinez, Camryn
    Olig, Emily
    Pachalla, Sarani
    Findley, Austin
    JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES, 2024,